GlassScriptPhysician profile
Corrine Heather Hamvas
NPI 1003104266
$327.73
in general payments reported to CMS, 2019-2025
11 companies · $67.05 in 2025
The $67.05 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.19 · 2021: $16.69 · 2022: $25.80 · 2023: $58.92 · 2024: $76.08 · 2025: $67.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $76.08 | 2024 | Ycanth |
| Cranial Technologies, INC | $47.55 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $43.14 | 2022-2023 | Jornay Pm |
| Tris Pharma INC | $42.34 | 2023-2025 | Dyanavel Xr |
| Shire North American Group INC | $23.50 | 2019 | |
| Glaxosmithkline, LLC. | $19.13 | 2019 | |
| Sobi, INC | $18.13 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.69 | 2021 | |
| Vertical Pharmaceuticals, LLC | $15.95 | 2025 | Relexxii |
| Collegium Pharmaceutical, INC. | $13.85 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corrine Hamvas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.